ERD

REALM | Real-world-data Enabled Assessment for heaLth regulatory decision-Making

01-01-2023

-

31-12-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

Real4Reg | Development, optimisation and implementation of artificial intelligence methods for real world data analyses in regulatory decision-making and health technology assessment along the product lifecycle

01-01-2023

-

31-12-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

ONCOVALUE | Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time

01-12-2022

-

30-11-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

More-EUROPA | More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

01-01-2023

-

31-12-2027

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

SQUEEZE | Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

01-12-2022

-

30-11-2027

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

PRIME-CKD | Personalized Drug Response: IMplementation and Evaluation in CKD

01-01-2023

-

31-12-2027

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

HT-ADVANCE | Improving treatment efficacy in hypertension by biomarker-guided personalised decision support

01-03-2023

-

28-02-2029

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

METHYLOMIC | DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

01-01-2023

-

31-12-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

REDDIE | Real-world evidence for decisions in diabetes

01-01-2023

-

31-12-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

Hypermarker | Personalised pharmacometabolomic optimisation of treatment for hypertension

01-01-2023

-

31-12-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

MORPHEUS | PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY

01-12-2023

-

30-11-2028

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

BIOTOOL-CHF | BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

01-10-2023

-

30-09-2028

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

INSAFEDARE | INNOVATIVE APPLICATIONS OF ASSESSMENT AND ASSURANCE OF DATA AND SYNTHETIC DATA FOR REGULATORY DECISION SUPPORT

01-11-2023

-

31-10-2026

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-02 New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

PoCCardio | Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)

01-12-2023

-

30-11-2028

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

OPADE | Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tool

01-12-2022

-

31-05-2027

Show more information

EU-Programme-Call

HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

Projects overview

Selected filters:

REALM | Real-world-data Enabled Assessment for heaLth regulatory decision-Making

Real4Reg | Development, optimisation and implementation of artificial intelligence methods for real world data analyses in regulatory decision-making and health technology assessment along the product lifecycle

ONCOVALUE | Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time

More-EUROPA | More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

SQUEEZE | Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

PRIME-CKD | Personalized Drug Response: IMplementation and Evaluation in CKD

HT-ADVANCE | Improving treatment efficacy in hypertension by biomarker-guided personalised decision support

METHYLOMIC | DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

REDDIE | Real-world evidence for decisions in diabetes

Hypermarker | Personalised pharmacometabolomic optimisation of treatment for hypertension

MORPHEUS | PROGNOSIS IMPROVEMENT OF UNPROVOKED VENOUS THROMBOEMBOLISM USING PERSONALIZED ANTICOAGULANT THERAPY

BIOTOOL-CHF | BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

INSAFEDARE | INNOVATIVE APPLICATIONS OF ASSESSMENT AND ASSURANCE OF DATA AND SYNTHETIC DATA FOR REGULATORY DECISION SUPPORT

PoCCardio | Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)

OPADE | Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tool